Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; ...
Financial Highlights, 2021 Revenue Guidance and Legal Update Preliminary 2020 revenue $353.9 million, compared to $306.5 million in 2019 Preliminary fourth quarter revenue $85.7 million, compared to $87.9 million in fourth quarter 2019 2021 revenue …